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during the COVID‑19 era and the correspond‑
ing period in 2019, we compared treatment logis‑
tics and clinical characteristics of patients with 
acute coronary syndromes (ACS) treated in these 
2 time intervals.
Methods The Polish Registry of Acute Coro‑
nary Syndromes (PL ‑ACS) is a national, prospec‑
tive registry which, since 2003, has been collect‑
ing data on acute coronary syndromes, includ‑
ing the incidence rate, patient clinical charac‑
teristics, therapeutic procedures as well as in‑
‑hospital and long ‑term outcomes. Currently, 
the registry data are entered by the attending 
physician via an online form. In 2019, the me‑
dian (interquartile range [IQR]) time from ad‑
mission of an ACS patient to reporting the pa‑
tient file in the computer system was 32.5 (9–
81) days. By the end of 2019, data on 749 821 
patients with ACS were gathered in the PL ‑ACS. 
More information on the registry was provid‑
ed previously.8
Patients with a diagnosis of STEMI or NSTE‑
MI hospitalized during the lockdown period of 
Introduction The coronavirus disease 2019 
(COVID‑19) pandemic has affected the entire 
global healthcare system. According to reports 
from different countries, the number of patients 
with myocardial infarction (MI) treated in 2020 
has decreased by 40% to 50% as compared with 
the corresponding period in 2019.1‑7 This refers 
both to patients with ST ‑segment elevation myo‑
cardial infarction (STEMI) and with non–ST‑
‑segment elevation myocardial infarction (NSTE‑
MI).2,5,6 A similar situation occurred in Poland, 
even though cardiology centers were prepared 
for activity and provided appropriate logistics.6,7
Except for data on the number of patients, so 
far, there has been little information on the clin‑
ical characteristics of MI patients referred for 
invasive diagnostics during the COVID‑19 pan‑
demic. An Italian registry showed that patients 
treated at cardiology centers during the epidem‑
ic were older than those treated in 2019. Addi‑
tionally, there were fewer women among pa‑
tients treated for MI.5
Based on the data from the Polish Registry of 



















S H O R T  C O M M U N I C A T I O N
Characteristics of patients from the Polish 
Registry of Acute Coronary Syndromes during 
the COVID‑19 pandemic: the first report
Michał Hawranek1, Marek Grygier2, Kamil Bujak1, Stanisław Bartuś3, Marek Gierlotka4, 
Wojciech Wojakowski5, Jacek Legutko6,7, Maciej Lesiak2, Piotr Pączek8, Andrzej Kleinrok9, Krzysztof 















S H O R T  C O M M U N I C A T I O N  Characteristics of patients with acute MI in the COVID‑19 era 193
The analysis included demographic data, clini‑
cal characteristics, and hospital procedures re‑
ported to PL ‑ACS by May 1, 2020. The approv‑
al of an ethics committee was not required for 
this analysis.
the COVID‑19 pandemic (March 1, 2020–May 
31, 2020) were included in the present analysis. 
The control group comprised patients with a di‑
agnosed MI hospitalized during the correspond‑
ing period in 2019 (March 1, 2019–May 31, 2019). 
Table 1 Characteristics of patients diagnosed with acute myocardial infarction before and during the coronavirus disease 2019 pandemic
Variable March–May 2019 (n = 7844)a March–May 2020 (n = 3457)b P value
Age, y 68 (61–76) 67 (60–75) <0.01
Male sex 5133 (65.44) 2293 (66.33) 0.36
Mode of admission Transfer from another hospital 3157 (40.42) 1223 (35.53) <0.001
Admission from home (through 
the EMS)
3236 (41.43) 1654 (48.05)
Self ‑admission to hospital 652 (8.35) 257 (7.47)
Referred by the general 
practitioner
503 (6.44) 190 (5.52)
Referred by the specialist 
outpatient clinic
262 (3.35) 118 (3.43)
Killip–Kimball classification I 6312 (81.57) 2807 (81.79) 0.73
II 983 (12.7) 417 (12.15)
III 228 (2.95) 103 (3)
IV 215 (2.78) 105 (3.06)
Diagnosis STEMI 2828 (36.05) 1308 (37.83) 0.07
NSTEMI 5017 (63.95) 2150 (62.17)
Sudden cardiac arrest before admission 213 (2.75) 118 (3.43) 0.049
Time from onset of pain to 
hospital admission
STEMI (direct admission) 180 (101–400) 180 (100–414) 0.73
STEMI (transfer from another 
hospital)
316 (171–720) 290 (146–697) 0.14
NSTEMI (direct admission) 409 (173–1285) 390 (173–1510) 0.78
NSTEMI (transfer from another 
hospital)
609 (298–1560) 660 (350–1589) 0.09
Time from admission to 
angiography, min
STEMI 25 (11–59) 21 (10–50.5) <0.001
NSTEMI 229 (61–839) 232.5 (68–897) 0.32
Left ventricular ejection fraction, % 50 (40–55) 48 (40–55) 0.16
Multivessel coronary artery disease 2994 (44.12) 1270 (42.42) 0.12
Percutaneous coronary interventions 6345 (81.40) 2839 (82.22) 0.30
CABG Yes, during hospitalization 15 (0.19) 7 (0.21) <0.001
No, but referred for CABG 234 (3.04) 119 (3.49)
No, but planned after discharge 296 (3.85) 71 (2.08)
Not planned 7148 (92.92) 3215 (94.23)
Intra ‑aortic balloon pump 31 (0.4) 8 (0.23) 0.16
Cardiogenic shock 167 (2.18) 83 (2.45) 0.39
Length of hospitalization, d 5 (3–7) 5 (3–7) 0.56
Data are presented as median (interquartile range) for continuous variables and number (percentage) of patients for categorical variables.
a Period from March 3, 2019 to May 31, 2019 
b Period from March 1, 2020 to May 31, 2020
Abbreviations: CABG, coronary artery bypass grafting; EMS, Emergency Medical Services; NSTEMI, non–ST ‑segment elevation myocardial infarction; STEMI, ST ‑segment 
elevation myocardial infarction
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with a healthcare professional for a longer time, 
which could have caused a higher frequency of 
prehospital SCA in 2020.
We observed significant differences in 
the mode of admission to a cardiology center. 
During the epidemic, more patients were trans‑
ferred by the Emergency Medical Services (EMS; 
Państwowe Ratownictwo Medyczne) directly to 
the hospital, with a lower number of patients 
transferred from other hospitals (41.43% vs 
48.05%, and 40.42% vs 35.53% in 2019 and 2020, 
respectively). In the present analysis, it is not 
possible to establish the cause of this phenom‑
enon. Perhaps the reorganization of the health‑
care system and difficulties with admitting and 
transferring patients to and from other hospitals 
resulted in a higher frequency of direct transport 
by the EMS, especially with regard to patients 
diagnosed with STEMI. Additionally, a short‑
er time from admission to coronary angiogra‑
phy was observed in STEMI patients (median 
[IQR], 25 [11–59] min vs 21 [10–50.5] min in 2019 
and 2020, respectively). It seems that the sus‑
pension of planned admissions and procedures 
could have caused a higher availability of car‑
diac catheterization laboratories. On the oth‑
er hand, new rules of patient admission intro‑
duced during the epidemic lengthened the ini‑
tial medical activities. It is possible this did not 
apply to STEMI patients.
We did not observe any differences in the in‑
cidence of multivessel disease or the number of 
percutaneous coronary interventions. Never‑
theless, during the pandemic, patients were sig‑
nificantly less frequently referred for coronary 
artery bypass graft (CABG) surgery (7.08% vs 
5.77% in 2019 and 2020, respectively). The num‑
ber of patients referred for CABG during initial 
hospitalization did not change, but the number 
of planned cardiosurgical procedures after hos‑
pital discharge was reduced. Similarly, as above, 
we may only hypothesize about the causes. It 
could be that during the epidemic, doctors and 
patients less frequently decided to carry on with 
the planned postdischarge treatment. It is also 
possible that in patients with a less advanced 
multivessel disease, subsequent percutaneous 
coronary interventions were more frequently 
performed during the initial hospitalization. 
However, we have no data that could explain 
this issue. Moreover, CABG is more often per‑
formed in NSTEMI patients, who were treated 
less often in 2020, which could have affected 
the total number of CABG procedures performed.
Limitations This is a retrospective analysis, 
therefore it involves all the inherent limita‑
tions. Data for 2019 and 2020 come from vari‑
ous reporting centers, which often represent dif‑
ferent medical units. Also, we do not yet have 
full clinical and angiographic characteristics of 
the analyzed patients, which prevents accurate 
Statistical analysis The  distribution of con‑
tinuous variables was nonnormal based on 
the Shapiro–Wilk test; therefore, they were pre‑
sented as medians and IQR and compared with 
the Mann–Whitney U test. Qualitative variables 
were presented as number and percentage of pa‑
tients and compared with the χ2 test. The P val‑
ue of less than 0.05 was considered significant. 
Statistical analysis was performed using the Sta‑
tistica software, version 13.3 (TIBCO Software 
Inc., Palo Alto, California, United States).
Results and discussion Data on treatment lo‑
gistics and clinical characteristics of the MI pa‑
tients are presented in TABLe 1. In comparison with 
the control group, patients treated in 2020 were 
slightly younger (median [IQR] age, 68 [61–76] 
years vs 67 [60–75] years, respectively), and more 
often experienced sudden cardiac arrest (SCA) 
prior to hospital admission (2.75% vs 3.43%, re‑
spectively). There was also a trend toward a high‑
er rate of STEMI during the COVID‑19 period 
(36.05% in 2019 vs 37.83% in 2020).
There is paucity of clinical data on MI pa‑
tients treated during the COVID‑19 pandemic. 
In an Italian registry, in contrast to our obser‑
vations, patients treated during the pandem‑
ic were older than those treated in the corre‑
sponding period in 2019.5 It is possible that fear 
of infection was greater among the elderly Pol‑
ish patients. Moreover, elderly patients more of‑
ten experience atypical symptoms, which, com‑
bined with the symptoms of COVID‑19 (dys‑
pnea, chest discomfort), could be confusing for 
those patients and discourage them from con‑
tacting the healthcare services. Data available 
both in Poland and across the world suggest that 
a greater reduction in the number of treated pa‑
tients is observed for NSTEMI than for STEMI 
patients.5,6 This may result from various fac‑
tors: NSTEMI symptoms are less conclusive, and 
the patient group is much more heterogeneous. 
Moreover, NSTEMI patients are usually older, 
and perhaps the above ‑mentioned factors re‑
garding the elderly also played a role. Addition‑
ally, the reorganization of the healthcare system 
might have affected the selection of patients re‑
ferred for invasive diagnostics in the first place. 
The frequency of prehospital SCA is often relat‑
ed to treatment delay. Data from Italy and Chi‑
na suggest that time from onset of pain to treat‑
ment has become significantly longer.1,5 Data 
from our analysis do not confirm these obser‑
vations. We have noticed no significant differ‑
ences in terms of the length of transport time 
from other hospitals for STEMI patients (me‑
dian [IQR], 316 [171–720] min in 2019 vs 290 
[146–697] min in 2020) and a trend toward lon‑
ger transport time for NSTEMI patients (median 
[IQR], 609 [298–1560] min in 2019 vs 660 [350–
1589] min in 2020). It cannot be ruled out, how‑
ever, that some of the patients waited for contact 
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comparison of the patients’ clinical profiles in 
the analyzed years. Additionally, the absolute 
number of patients treated in 2020 cannot be 
directly compared with data from 2019, as not 
all patients during this period were reported to 
the PL ‑ACS pending data analysis.
Conclusions The COVID‑19 epidemic caused 
a reduction in the number of patients admit‑
ted to hospitals with a diagnosis of STEMI 
and NSTEMI. The MI patients treated during 
the COVID‑19 pandemic were more often taken 
to the hospital by direct transport of the EMS. 
Moreover, prehospital cardiac arrest was more 
frequent. The time from admission to coronary 
angiography was shorter among the STEMI pa‑
tients, and the number of patients referred for 
CABG was lower.
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